Market Dynamics
Drivers for the Global Cannula Market
A Surge In Cases Of Diabetes And Obesity Drives The Market
Globally, over 234 million procedures are performed annually, per the National Center for Biotechnology Information. Medical cannulae are necessary for the administration of therapeutic and diagnostic chemicals, as well as anesthetic procedures, suction, and irrigation.
In addition, a substantial proportion of the population prefers minimally invasive procedures. According to the National Center for Biotechnology Information, proper surgical equipment (including medical cannulae) has the potential to prevent 6-7% of fatalities.
In recent years, worldwide obesity rates have risen dramatically. As a result of the increasing prevalence of lifestyle disorders such as obesity and diabetes, the number of surgical procedures performed around the world is increasing, thereby contributing to the development of the cannula industry.
In addition, the growing elderly population and the preference for minimally invasive procedures (MIS) are driving cannula market growth.
Minimally Invasive Surgeries Are Driving the Market
In the medical field, minimally invasive surgical procedures are gaining popularity. For the treatment of cardiovascular diseases, there has been a rapid rise in the popularity of minimally invasive procedures. This is due to the fact that minimally invasive procedures cause less surgical trauma and produce a more aesthetically pleasing outcome. It provides benefits such as smaller incisions, reduced risk of infection, smaller scars, less blood loss, and less pain and trauma. As a result, there is a growing preference for minimally invasive surgical procedures, which is anticipated to stimulate the market for cannulas.
Restraints for the Global Cannula Market
A Shortage Of Trained Medical Professionals Hampers The Market
In surgical procedures, medical cannulae are unavoidable; however, improper cannulation can result in hypersensitivity, extravasation, infiltration, phlebitis, and systemic or local infections.
In addition, IV cannulation of a newborn could be excruciatingly unpleasant if not performed with care. In addition, only a handful of institutions around the world offer training in medical cannulation. Lack of competent labour and cannulation errors are likely to impede market expansion in the foreseeable future.
Opportunities for the Global Cannula Market
Ease of Manufacturing Will Bring In New Opportunities
In all regions, the use of syringes and cannulas is increasing in the healthcare industry. Due to the fact that these goods are simpler to produce than other medical equipment, there is a greater chance that more manufacturers will enter the market and earn substantial profits.
Relevant is also the fact that the market is highly fragmented, comprised of numerous regional and local firms. As a result, the industry is incredibly competitive, posing a threat to existing businesses. As a result, market leaders are continuously working on strategic developments and releasing new products, a factor that drives the cannula market growth.
Segmental Analysis
This market can be segmented on the basis of product, type, material, size, end-use, competitors and regions.
On the basis of product, the market for cannulas is divided into cardiac (arterial, venous, cardioplegia, and other) dermatology, nasal, and other segments. In 2021, the largest cannula market share was held by the cardiac segment. This is because of the prevalence of cardiovascular disease. The prevalence of cardiovascular disease is on the rise due to factors such as a shift toward a more sedentary lifestyle, increased consumption of processed foods, and a decline in physical activity. In addition, an increase in the geriatric population, which is at a higher risk of developing these diseases, also contributes to the dramatic rise in cardiovascular diseases. Consequently, the rise in the prevalence of cardiovascular diseases is the primary reason for the dominance of the cardiac segment in the cannula market.
The dermatology segment is anticipated to experience significant expansion during the projection period. This is because microcannula is used more frequently to prevent difficulties during and after surgeries. Additionally, there has been a noticeable increase in the number of aesthetic procedures performed, which is predicted to increase demand for the dermatology sector significantly. In the United States, physicians perform more than 15 million cosmetic surgery treatments annually, according to a research paper published in 2021. Thus, segment growth during the forecast period is anticipated to boost MIS penetration.
The market is segmented by type into neonatal cannulae, straight cannulae, winged cannulae, a wing with a port, and winged with a stop cork. In 2021, the segment of cannulae that are straight held the largest market share. This is due to the fact that its design makes it easier to use. The product's extra-sharp needle also facilitates insertion. As a result, these types of cannulae are utilized in cardiac surgeries in order to prevent any mishaps and reduce any unnecessary delays that could cause the procedure to be extended.
Neonatal cannulae are anticipated to see the highest growth and CAGR during the forecast period. The rise in the occurrence of respiratory issues in newborns is the main factor driving this segment's expansion. Neonatal cannulae are ideal for neonates in high-flow oxygen therapy because of their soft and flexible nature. In 2016, 33.3% of all newborn admissions at >28 weeks' gestation had respiratory issues as their primary reason for admission, excluding children with syndromes and those with congenital or surgical illnesses, according to a study released by the National Library of Medicine.
The market is segmented into plastic, metal, and silicone based on material. Due to its increased adoption rate in both in-patient and out-patient procedures, the plastics segment held the largest market share in 2021. In shoulder arthroscopy, the majority of plastic cannulas are translucent, enabling surgeons to see instruments and sutures passing through the cannula. As a result, it is suitable for use in the vast majority of procedures, which will lead to its dominance throughout the period being forecasted.
During the forecast period, the silicone segment is expected to experience the greatest growth. This is attributable to the increasing use of silicone cannulas in oxygen therapies, which ensure the continuous delivery of oxygen to surgical patients and those with respiratory disorders. In addition, silicone cannulas are soft and flexible, making them a popular choice among medical professionals and patients.
14G, 16G, 18G, 20G, 22G, 24G, and 26G are market segments based on size. Colors represent various sizes of cannulas. In 2021, the 18G size held the largest market share, a trend that is anticipated to continue throughout the forecast period. This is due to the fact that the 18G cannula size is the most commonly used in hospitals for both adults and adolescents. 18G cannulas are used to administer blood products and drugs. These cannulas are intended for speedy blood transfusion. In addition, these are utilized for protocols involving computed tomography/pulmonary embolism and other tests requiring large IV sizes.
The most significant increase is anticipated for 22 G-size cannulas, projected to expand at a sizable CAGR during the forecast period. This is explained by the narrow gauge size of the device, which enables a faster fluid flow in patients with intricate veins. Most patients are successfully treated with one long peripheral cannula throughout their treatment without needing additional cannulation, according to a research study published in the Journal of Vascular Access in 2018.
Based on the final application, the market is segmented into hospitals, ambulatory surgical centers, and others. Blood banks, research facilities, and pathology labs comprise the remainder of the market.
On the basis of the final application, the market is segmented into hospitals, ambulatory surgical centres, and others. Blood banks, research facilities, and pathology labs make up the remainder of the market. In 2021, the largest market share was held by the hospital's segment. This is due to the increase in hospitalization rates for numerous causes and treatments. Cannulas are utilized in numerous hospital specialties, including orthopedic surgery, cardiovascular surgery, neurology, gynecology, general surgery, oxygen therapy, and dermatology.
The fastest growth is anticipated in ambulatory surgical centers over the predicted period. Modern healthcare facilities called ambulatory surgery centers to provide same-day surgical services in addition to preventive and diagnostic procedures. As a result, more people choose to have surgery at ambulatory surgical facilities rather than hospitals. As a result, there are more ambulatory surgery centers opening up. There are currently about 9,280 ambulatory surgery centers in the United States.
Top Key Players
Medtronic
Becton Dickinson (BD)
Edward Lifesciences
LivaNova
Smiths Medical
Boston Scientific Corporation
Others
